Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11026 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zarogoulidis, P., Huang H., Bai C., Kosmidis C., Trakada G., Veletza L., et al. (2017).  Endobronchial ultrasound convex probe for lymphoma, sarcoidosis, lung cancer and other thoracic entities. A case series.. Respir Med Case Rep. 22, 187-196.
Zarogoulidis, P., Darwiche K., Walter R., Li Q., Teschler H., Freitag L., et al. (2013).  Research spotlight: sirolimus-coated stents for airway tracheal stenosis: a future 3D model concept with today's knowledge.. Ther Deliv. 4(9), 1093-7.
Zarogoulidis, P., Papadopoulos V., Maragouli E., Papatsibas G., Karapantzos I., Bai C., et al. (2018).  Tumor heterogenicity: multiple needle biopsies from different lesion sites-key to successful targeted therapy and immunotherapy.. Transl Lung Cancer Res. 7(Suppl 1), S46-S48.
Zarogoulidis, P., Eleftheriadou E., Sapardanis I., Zarogoulidou V., Lithoxopoulou H., Kontakiotis T., et al. (2012).  Feasibility and effectiveness of inhaled carboplatin in NSCLC patients.. Invest New Drugs. 30(4), 1628-40.
Zarogoulidis, P., Darwiche K., Sakkas A., Yarmus L., Huang H., Li Q., et al. (2013).  Suicide Gene Therapy for Cancer - Current Strategies.. J Genet Syndr Gene Ther. 4,
Zarogoulidis, P., Petridis D., Sapalidis K., Tsakiridis K., Baka S., Vagionas A., et al. (2020).  Lung cancer biopsies: Comparison between simple 22G, 22G upgraded and 21G needle for EBUS-TBNA.. J Cancer. 11(21), 6454-6459.
Zarogoulidis, P., Kioumis I., Tsiouda T., Pezirkianidis N., Ritzoulis C., Huang H., et al. (2014).  A 3D Polymer Model for Future Nutrition Design Novel Nutrition Approach for Cystic Fibrosis, Ulcerative Colitis and Crohn's Disease.. J Nanomedine Biotherapeutic Discov. 4(2), 128.
Zarogoulidis, P., Alexandropoulou I., Romanidou G., Konstasntinidis T. G., Terzi E., Saridou S., et al. (2011).  Community-acquired pneumonia due to Legionella pneumophila, the utility of PCR, and a review of the antibiotics used.. Int J Gen Med. 4, 15-9.
Zarogoulidis, P., Chatzaki E., Hohenforst-Schmidt W., Goldberg E. P., Galaktidou G., Kontakiotis T., et al. (2012).  Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.. Cancer Gene Ther. 19(9), 593-600.
Zarogoulidis, K., Zarogoulidis P., Darwiche K., Boutsikou E., Machairiotis N., Tsakiridis K., et al. (2013).  Treatment of non-small cell lung cancer (NSCLC).. J Thorac Dis. 5 Suppl 4, S389-96.
Zarogoulidis, P., Huang H., Tsiouda T., Sardeli C., Trakada G., Veletza L., et al. (2017).  Immunotherapy "Shock" with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma.. Respir Med Case Rep. 22, 283-286.
Zarogoulidis, P., Sapalidis K., Kosmidis C., Tsakiridis K., Huang H., Bai C., et al. (2020).  Stents for small airways: current practice.. Expert Rev Respir Med. 14(10), 969-972.
Zarogoulidis, P., Yarmus L., & Zarogoulidis K. (2013).  New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer.. Ther Deliv. 4(10), 1221-3.
Zarogoulidis, P., Chinelis P., Athanasiadou A., Tsiouda T., Trakada G., Kallianos A., et al. (2017).  Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases.. Respir Med Case Rep. 22, 101-105.
Zarogoulidis, K., Boutsikou E., Zarogoulidis P., Darwiche K., Freitag L., Porpodis K., et al. (2013).  The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis.. Onco Targets Ther. 6, 1493-500.
Zarogoulidis, P., Terzi E., Kouliatsis G., Androuli S., Kontakiotis T., Zaramboucas T., et al. (2011).  Orbital metastases as the first manifestation of lung adenocarcinoma.. Case Rep Ophthalmol. 2(1), 34-8.
Zarogoulidis, P., Trakada G., & Zarogoulidis K. (2013).  A chrono-target chemotherapy treatment model for lung cancer treatment.. Ther Deliv. 4(1), 5-8.
Zarogoulidis, P., Hohenforst-Schmidt W., Huang H., Sapalidis K., Kosmidis C., Tryfon S., et al. (2020).  Vapor for lung volume reduction; pros and cons.. Expert Rev Respir Med. 14(12), 1189-1195.
Zarogoulidis, P., Petridis D., Ritzoulis C., Darwiche K., Spyratos D., Huang H., et al. (2013).  Establishing the optimal nebulization system for paclitaxel, docetaxel, cisplatin, carboplatin and gemcitabine: back to drawing the residual cup.. Int J Pharm. 453(2), 480-7.
Zarogoulidis, P., Kosmidis C., Fyntanidou V., Barmpas A., Koulouris C., Aidoni Z., et al. (2019).  Elastography during convex-probe (endobronchial ultrasound) for optimal biopsy sample and gene identification in non-small-cell lung cancer.. Biomark Med. 13(14), 1153-1156.
Zarogoulidis, P., Papadopoulos V., Maragouli E., Papatsibas G., Sardeli C., Man Y-G., et al. (2018).  Nivolumab as first-line treatment in non-small cell lung cancer patients-key factors: tumor mutation burden and PD-L1 ≥50.. Transl Lung Cancer Res. 7(Suppl 1), S28-S30.
Zarogoulidis, P., Petridis D., Ritzoulis C., Li Q., Huang H., Ning Y., et al. (2013).  Further experimentation of inhaled; LANTUS, ACTRAPID and HUMULIN with todays' production systems.. Int J Pharm. 458(1), 39-47.
Zarogoulidis, P., Kioumis I., Ritzoulis C., Petridis D., Darwiche K., Porpodis K., et al. (2013).  New insights in the production of aerosol antibiotics. Evaluation of the optimal aerosol production system for ampicillin-sulbactam, meropenem, ceftazidime, cefepime and piperacillin-tazobactam.. Int J Pharm. 455(1-2), 182-8.
Zarogoulidis, P., Kouliatsis G., Papanas N., Spyratos D., Constantinidis T. C., Kouroumichakis I., et al. (2011).  Long-term respiratory follow-up of H1N1 infection.. Virol J. 8, 319.
Zarogoulidis, P., Porpodis K., Kioumis I., Petridis D., Lampaki S., Spyratos D., et al. (2014).  Experimentation with inhaled bronchodilators and corticosteroids.. Int J Pharm. 461(1-2), 411-8.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.